In 2014, more than one-third of Google Ventures' funds were invested in health care and life sciences, and in 2013 this area accounted for only 9% of Google Ventures. The author has compiled the data of the various fields of Google Ventures investment in the past three years as shown below.
Bill Maris, head of Google Ventures, said Google will continue to invest in this area, hoping to take advantage of the explosion of health data and innovative data analysis models. Maris also said: In 2015, Google will have more interest in life sciences without any surprises. Maris sees a large number of medical health segments worth investing in, including oncology, spinal regeneration, brain function and cognitive problem repair.
Comparing the distribution of investment in 2013 and 2014, Google was very interested in consumer Internet startups, which accounted for 66% in 2013, of which Google invested $258 million in Uber, but in 2014 it plummeted to 8%. As of today, Google Venture has dropped $425 million, which is much higher than the $300 million in the past two years.
Google’s interest in the medical field has grown stronger. In early 2013, Andrew Conrad, an expert in genetic research, was recruited to run the life sciences team at Google X. Conrad's team is analyzing the genome and molecular information from thousands of individuals to create a more complete picture of the healthier humans that Google expects.
We are a professional Chinese supplier of Reagents Material;we supply various products of Chemical Reagent, Standard Substance ; and we can providing product images and basic parameters with each Reference Substance and Reagent Product, such as Proteinase K, Bilirubin Powder. Look forward to your cooperation!
Chemical Reagent,Standard Substance,Reference substance,Proteinase K,Bilirubin PowderÂ
Xi'an Quanao Biotech Co., Ltd. , https://www.quanaobiotech.com